Verbal Stimulation of Orientation on Emergence Agitation

October 10, 2022 updated by: Bo Rim Kim, Seoul National University Hospital

Effect of a Repeated Verbal Stimulation of Orientation on Emergence Agitation After General Anesthesia: a Randomized Double-blind Trial

The purpose of this study is to investigate whether information of the orientation such as time, place, and patient's own name can reduce emergence delirium after general anesthesia.

Study Overview

Study Type

Interventional

Enrollment (Actual)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing elective laparoscopic or robot-assisted abdominal surgery

Exclusion Criteria:

  • Patients' refusal
  • Change in operation schedule
  • American Society of Anaesthesiologists (ASA) physical status Ⅳ
  • Day surgery
  • BMI ≥35
  • Neurocognitive impairment, hearing disorder
  • Psychological drug intake
  • Experience of general anesthesia or sedation within 1 month

Drop out Criteria

  • Changes in operation schedule (e.g. unexpected collaborative surgery, conversion to laparotomy, delay of the schedule to night-duty hours)
  • Significant protocol violation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Orientation
Information of orientation (time, place, patient's own name) is repeatedly provided during emergence.
During emergence, recorded voice of an investigator giving Information of orientation (time, place, patient's own name) is repeatedly played from noise-cancelling headphones
Active Comparator: Name
As usual, patient is recovered from general anesthesia with his/her name called.
During emergence, recorded voice of an investigator calling the patient's name is repeatedly played from noise-cancelling headphones

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of emergence agitation at operating room (OR)
Time Frame: 20 minutes after anesthesia emergence
Riker sedation agitated scale ≥5
20 minutes after anesthesia emergence

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of dangerous emergence agitation
Time Frame: 20 minutes after anesthesia emergence
Riker sedation agitated scale =7
20 minutes after anesthesia emergence
maximal Riker sedation agitated scale during emergence
Time Frame: 20 minutes after anesthesia emergence
maximum value of Riker sedation agitated scale during emergence
20 minutes after anesthesia emergence
Time to emergence
Time Frame: 20 minutes after anesthesia emergence
Time from anesthetics off to eye opening/extubation/discharge from OR
20 minutes after anesthesia emergence
Bispectral index (BIS)
Time Frame: 20 minutes after anesthesia emergence
BIS value at desflurane discontinuation/verbal response/extubation
20 minutes after anesthesia emergence
Incidence of emergence agitation at PACU
Time Frame: 30 minutes after PACU adminstration
Riker sedation agitated scale ≥5
30 minutes after PACU adminstration
Incidence of postoperative delirium
Time Frame: 30 minutes after PACU adminstration / Postoperative 24 hours
Delirium scale (CAM)
30 minutes after PACU adminstration / Postoperative 24 hours
Postoperative Pain
Time Frame: 10/20/30 minutes after PACU administation / Postoperative 24 hours
NRS score (0-11) of pain
10/20/30 minutes after PACU administation / Postoperative 24 hours
PACU stay
Time Frame: up to 3 hours after PACU administration
Length (hours) of PACU stay
up to 3 hours after PACU administration
Postoperative opioid consumption
Time Frame: 30 minutes after PACU adminstration / Postoperative 24 hours
Postoperative opioid requirement
30 minutes after PACU adminstration / Postoperative 24 hours
Analgesics requirement
Time Frame: Postoperative 24 hours
Analgesics other than opioid requirement
Postoperative 24 hours
Postoperative quality of recovery
Time Frame: Postoperative 24 hours
Korean version of quality of recovery-15
Postoperative 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bo Rim Kim, M.D., Seoul National University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 9, 2021

Primary Completion (Actual)

April 20, 2022

Study Completion (Actual)

April 27, 2022

Study Registration Dates

First Submitted

October 22, 2021

First Submitted That Met QC Criteria

October 25, 2021

First Posted (Actual)

November 3, 2021

Study Record Updates

Last Update Posted (Actual)

October 13, 2022

Last Update Submitted That Met QC Criteria

October 10, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergence Delirium

Clinical Trials on Giving orientation with headphones

Subscribe